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Somatic Hypermutation of Immunoglobulin Genes
Is Linked to Transcription Initiation
Andrew Peters* and Ursula Storb² the mutations are simply the result of an undirected error
prone DNA polymerase. Second, besides the variable*Department of Biochemistry
and Molecular Biology region, bacterial sequences, a globin gene, or artificial
substrates can also be somatically mutated in the con-²Department of Molecular Genetics
and Cell Biology text of an immunoglobulin transgene (Azuma et al., 1993;
Yelamos et al., 1995; Klotz et al., submitted), suggestingUniversity of Chicago
Chicago, Illinois 60637 that the targeted sequence itself does not initiate the
mutation process. Third, hotspots of mutation are fre-
quently observed and are at different positions in differ-
ent sequences, suggesting that the process is influ-Summary
enced by the primary sequence (Betz et al., 1993).
Fourth, the 59 boundary of mutations is within the leaderTo identify DNA sequences that target the somatic
intron. Mutations upstream of the transcriptional starthypermutation process, the immunoglobulin genepro-
site are extremely rare (Both et al., 1990; Gearhart andmoter located upstream of the variable (V) region was
Levy, 1991; Rada et al. 1994; Rogerson, 1994). Fifth,duplicated upstream of the constant (C) region of a k
there is no defined 39 end point of the mutation tract.transgene. Normally, k genes are somatically mutated
However, the mutations extend only over about 1.5 kbonly in the VJ region, but not in the C region. In B cell
with a slow decline of the frequency beyond the J regionhybridomas from mice with this k transgene (P59C),
that is joined to the V gene (Rogerson, 1994). The reachboth the VJ region and the C region, but not the region
of mutations 39 depends on the position of the VJ jointbetween them, were mutated at similar frequencies,
in a particular gene: when a Vk gene is rearranged tosuggesting that the mutation mechanism is related
Jk1, the mutations cease before Jk5, none are found into transcription. The downstream promoter was not
the JC intron. When Vk is joined to Jk5, point mutationsoccluded by transcripts from the upstream promoter.
can be found as far as 1 kb into the JC intron (WeberIn fact, the levels of transcripts originating from the
et al., 1991a, 1991b).two promoters were similar, supporting a mutation
The molecular process that results in the point muta-model based on initiation of transcripts. Several ªhot-
tions is unknown. The use of mice carrying immunoglob-spotsº of somatic mutation were noted, further dem-
ulin transgenes has made it possible to study the DNAonstrating that this transgene has the hallmarks of
sequences required for somatic mutation (O'Brien et al.,somatic mutation of endogenous immunoglobulin
1987). It appears that the genes have to be transcription-genes. A model linking somatic mutation to transcrip-
ally active. Immunoglobulin transgenes with embeddedtion-coupled DNA repair is proposed.
bacterial b-gal and supF sequences were found not to
be transcribed or mutated (J. Hackett and U. S., unpub-Introduction
lished data). Furthermore, absence of the k-39 enhancer
greatly reduces, and, absence of the k-intron enhancerImmunoglobulin genes areassembled duringearly B cell
eliminates somatic mutation of k transgenes (Betz etdevelopment and their variable (V) regions are further
al., 1994). However, measurements of stable transcriptsmodified by somatic mutations occurring in mature B
from these transgenes have given conflicting results aslymphocytes stimulated by antigen (reviewed by Storb,
the transgenes without the intron enhancer were highly1987). The mutation process takes place in the dark
transcribed in hybridomas, yet unmutated.zone of germinal centers of peripheral lymphoid tissues
To determine more directly whether transcription af-in which the activated B cells proliferate for a few cell
fects somatic mutation, we constructed transgenic micegenerations. Each germinal center is oligoclonal (Jacob
with a second transcriptional promoter in the middle ofet al., 1991). The V regions of the B cells of a given
a k transgene (Figure 1) and determined whether it couldgerminal center are related in a way that allows con-
direct somatic mutation to downstream sequences.struction of a family tree based on the consecutive ac-
crual of point mutations. B cells with mutations in the
variable region sequences that confer a higher affinity Results
for the immunizing antigen are positively selected and
enriched. B cells that have acquired stop codons or Transgenic Mice
Transgenic mice were produced with the somatic muta-mutations that decrease the antibody affinity die by
apoptosis. tion test gene, P59C (Figure 1). One mouse line, 330,
which carries only three copies of the transgene wasThe important features of the somatic mutation pro-
cess are the following (reviewed by Neuberger and used for detailed study of the somatic mutation process.
To enrich for cells with mutated immunoglobulin genes,Milstein, 1995; Storb, 1996): First, the mutations are
mainly point mutations, with very rare deletions or inser- B cell hybridomas were produced from the spleen of
mice immunized with PC±keyhole limpet hemocyanintions of mostly single nucleotides. There is clear evi-
dence for a strand bias, suggesting that one strand of (KLH) (see Experimental Procedures). Since we had
found previously that immunoglobulin G (IgG)-secretingthe double helix is preferentially or exclusively targeted
(Gearhart and Levy, 1991) and making it unlikely that hybridomas from mice with the original k-167 transgene
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Figure 1. Structure of the P59C transgene
The transgene was created from the re-
arranged k 167 light chain gene. A region from
the leader-variable intron to 4.25 kb upstream
is inserted upstream of the constant region.
The matrix attachment and intronic enhancer
regions (ME) were moved from the J±C intron
to downstream of the constant region. Stop
codons were incorporated into both of the leader regions. A 10 bp segment was inserted into the HpaI site of the constant region. All other
aspects of the transgene are identical to the pVC167 transgene (O'Brien et al., 1987).
(O'Brien et al., 1987) show a higher frequency of somatic for mutations in the transgenes using DGGE and se-
quencing.mutations than IgM-secreting ones (A. P. and U. S.,
unpublished data), we only analyzed IgG1 hybridomas.
The hybridomas were first screened for mutations by Both Variable and Constant Regions Are
Mutated When Both Are Precededdenaturing gradient gel electrophoresis (DGGE). Two
polymerase chain reaction (PCR) primer sets spanning by a Transcriptional Promoter
Sequences of the test transgenes of IgG-producinga total of 642 bp across the variable (V) region and the
J±C intron region were used to detect mutations. By hybridomas were amplified, cloned, and sequenced
across the VJ region and into the JC intron (500 bp wereDGGE analysis, 9 of 25 IgG-secreting hybridomas had
mutations in the region examined (8 of these were se- sequenced in 9 hybridomas), the C region (350 bp were
sequenced in 4 hybridomas, 782 bp in 6 hybridomas,quenced and are included in Figure 2). DGGE did not
give a readable pattern for the C region, thus the C and 836 bp in 3 hybridomas), and a region upstream of
the C region promoter (350 bp sequenced in 5 hybrido-regions of 8 hybridomas that had mutations in the V
region as well as five randomly chosen IgG1 hybridomas mas, and 520 bp sequenced in 3 hybridomas) (Figure
2). Fortuitously, the three transgene copies can be dis-without VJ mutations were sequenced. As a negative
control, kidney DNA from the same mice was analyzed tinguished: copy (a) contains a germline mutation at
Figure 2. Position and Distribution of Mutations in the Variable and Constant Regions of the Transgene P59C
Position 1, cap site (the numbering is different from Hackett et al., 1990). The regions sequenced from each hybridoma are represented by a
thick horizontal bar following the hybridoma name. All three copies were sequenced in all hybridomas; if there were mutations, only the
mutated copy is shown. Germline mutations are marked by open triangles, while somatic mutations are marked by inverted open triangles.
The base change and its nucleotide position relative to the appropriate promoter are indicated above each inverted open triangle. The primers
used for amplification and cloning (APV11, JRH2, APV11, APC4, KD2, APC4) and sequencing primers (Vk3t, Vk7, APC1, APC4, KD2, KD4)
are shown on the map. Mutational hotspots A±E are shown as closed inverted triangles and marked.
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position 556 in the V region; copy (b) contains a germline cDNAs of the hybridomas in which both the VJ and the
C regions are mutated. In both the 3F2.2 and the 6D5.2mutation at position 733 of the C region; and copy (c)
hybridomas (Figure 2) the mutations in the VJ and Chas no germline mutations. These mutations are also
regions must be in the same transgene copy, since theyobserved in kidney DNA and may have arisen during
appear in the same RNA molecule. It is not clear whytransgene integration.
the mutations in the V and C regions are in the sameSomatic point mutations were found both in the VJ
transgene copy.region and C region. For each region, at least ten clones
There are five ªhotspotsº of mutation in the VJ regionfrom each hybridoma were sequenced from the first
and the JC intron (Figure 2, A±E), i.e., nucleotides thatPCR to have an over 98% confidence level that each of
are mutated in more than one hybridoma. One of these,the three transgene copies was sequenced at least
position 847 (D) in the V region, has also been observedonce. All point mutations were confirmed in a second
to be mutated in the basic k-167 transgene without theindependent PCR, except the C region proximal intron
downstream promoter (Rogerson et al., 1991). This hot-mutation 177A→G in 2B5.2 (Figure 2). All PCRs were
spot, occuring here in the JC intron, is at the G of theperformed using Pfu polymerase. We found a PCR error
sequence AGT. AGY,a serine codon, has been observedfrequency with Pfu of 1.3 3 1025 mutations/nt/30 cycles
to be a hotspot in other V genes (Betz et al. 1993). The(data not shown). The published error frequency is 1.6
hotspots C and E are also in AGY triplets. Furthermore,3 1026 per cycle for Pfu, i.e., in 30 cycles 4.8 3 1025
three additional mutations that occur only once each in(Lundberg et al., 1991). Assuming that the transgene
our sample, also occur in AGY triplets, one in the Vcopies that were negative by DGGE had no mutations,
region (3A2, AGT 529 G→C), and two in C region flanksthe VJ region mutation frequency was 4.98 3 1024 muta-
(6D5, AGC 222 G→A; 3B4, AGC 673 C→T). The hotspotstions/nt (24 mutations in 642 bp/3 copies/25 hybrido-
(A), (B), (D), and (E) are not germline mutations in thismas). This is perhaps an underestimate, as not all muta-
transgenic mouse, since the resulting mutation variestions may be detected by DGGE.
(A560 →T or →G; A593 →C or →G; G847 →A or →C;The mutation frequency established for the C region
C937 →T or →G or →A). Hotspot (C) (C603 →T) is notand its vicinity was 3.9 3 1024 mutations/nt (10 muta-
a germline mutation either, since this transgene copy,tions/3 copies per 350 bp in 4 hybridomas, per 782 bp
which carries a known germline mutation, does not havein 6 hybridomas, and per 836 bp in 3 hybridomas). This
the C603 mutation in five other hybridomas. Hotspotsis not biased by DGGE selection, however, 8 of the 13
(A), (B), and (D) each are mutated in different copies ofhybridomas had mutations in the VJ region. Thus, the
the transgene. These hotspots must be due to the so-mutation frequency over the C region and its vicinity is
matic mutation mechanism, since, owing to the stopsimilar to that found over the VJ region. This is vastly
codon in the leader, they could not have been selecteddifferent from the situation in endogenous or transgenic
on the protein level.k genes with only the upstream promoter in which the
C regions are spared from mutation. In 12,665 bp of C
region sequences in immunoglobulin genes whose V
Transcripts from the Two Promoters Are
regions are mutated no mutations were found, making of Similar Abundance
the mutation frequency < 8 3 1025 mutations/nt (Gear-
The presence of a transcriptional promoter upstream of
hart and Bogenhagen, 1983; Hackett et al., 1990; Rog-
the C region can only be implicated in the mechanism
erson et al., 1991; Chien et al., 1988; Hamlyn et al., 1981). creating somatic mutations if transcripts originate from
A region of 520 bp or 350 bp intervening between the this promoter. It is possible that the downstream pro-
VJ gene and the C gene was not mutated (Figure 2). This moter may be inhibited by elongating transcriptional
region was sequenced exhaustively from 6 hybridomas complexes initiating at the upstream promoter (Adhya
that had mutations in the VJ region of one or two and Gottesman, 1982; Cullen et al., 1984; Proudfoot,
transgene copies. Two of these hybridomas also had 1986). Ideally, transcriptional rates should be measured
mutations in the C region of one transgene copy. Thus, from the two promoters in the centroblasts of germinal
when mutations occur in the V region the mutation tract centers that are presumed to be the mutating cell type
does not continue throughout the transgene with the (reviewed by Neuberger and Milstein, 1995). Since this
two promoters. This finding recapitulates the somatic is technically not feasible, we have determined the levels
mutation pattern in the endogenous and transgenic VJ5± of stable transcripts initiating from the two promoters
k167 genes in which point mutations are not seen be- in hybridoma cells. There is no a priori reason why tran-
yond z1 kb 39 of Jk5 (Gearhart and Bogenhagen, 1983; scripts from the two promoters should differ in stability.
Hackett et al., 1990). In the P59C transgene, the mutation One would expect, therefore, that the RNA levels reflect
process must also initiate 59 of the C region. the transcription rates. Levels of full-length transgenic
These findings suggest that the region upstream of k mRNA (LVJC, initiated from the V promoter) and of
the V gene that has been duplicated directly upstream a leader-C spliced transcript (LC, initiated from the C
of the C region in this transgene is responsible for the promoter) were determined by an RNase protection
targeting of a mutator mechanism to the C region. For assay using poly(A)1 RNAs from one hybridoma (3F2),
reasons explained in the Discussion, we favor a model in which both the VJ and C regions are mutated in the
in which the targeting involves the transcriptional pro- same transgene copy, and in two hybridomas (2B5 and
moter. 3A2), in which only the VJ region is mutated (Figure
To determine the mutation distribution between the 3). As a control, hybridoma (CE9) transcripts from a k
transgene that contains only the upstream promoterthree transgene copies, we sequenced the cloned
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Figure 4. Schematic Illustration of the Distribution of Somatic Muta-
tions
Figure 3. Ribonuclease Protection Analysis (Top) In wild-type k genes, including transgenes, the region that is
somatically mutated extends from just after the promoter to aboutPoly(A)1 hybridoma RNAs were hybridized with a cloned cDNA
probe consisting of spliced LC region sequences (boxes), flanked 1.5 kb downstream (Lebecque and Gearhart, 1990; Rogerson, 1994;
Weber et al., 1991a, 1991b). The C region is unmutated.by vector (broken line). C* indicates the P59C constant region with
a 10 bp insertion. L±C*, L±VJ±C*, and endogenous C messages can (Bottom) In the P59C transgene, where the transcriptional promoter
has been duplicated upstream of the C region, point mutations arebe distinguished from one another by the resulting band sizes and
are indicated in the diagram. The quantitative data from phos- present in two waves over the VJ region and over the C region.
phorimager analysis are shown in the table at the bottom. All data
were first normalized to b-actin expression and the normalized
counts are shown in the table. The values in parentheses for CE9
C-leader to C) are spliced out much more efficiently thanand SP2/0 are readings at the positions of L±VJ±C* and L±C*, re-
long introns (V-leader to C) (Peterson and Perry, 1989;spectively. Hybridomas 3F2.2, 2B5.2, and 3A2.2 are from P59C
Shutt, 1993).transgenics, hybridoma CE9 is from a k-167 transgenic mouse.
Discussion
were determined (transgenic mouse line 233-8; Hackett
et al., 1990). Quantitation by phosphorimager analysis The P59C transgene was designed to determine whether
transcription is directly involved in somatic mutation ofshowed that there is clearly no discrimination against
transcripts from the downstream promoter. Full-length immunoglobulin genes. The findings suggest that se-
quences that are normally present upstream of the Vkk mRNAs from endogenous k genes could be distin-
guished from the transgenic transcripts (see Experimen- region can confer mutability to Ck and flanking regions
that are normally not targets for somatic hypermutation.tal Procedures) and were found to be at least ten times
more abundant than the transgenic transcripts. The en- It is unlikely that the repositioning of the k intron en-
hancer from the JC intron to 39 of the C region causeddogenous transcripts are presumably derived from the
two k genes of the fusing line and from one or two this effect. First, the mutations in the V region were
of the same distribution and frequency as those foundrearranged k genes of the spleen B cell. Since the
transgenic and endogenous RNAs come from an ap- previously in the same transgene without the shifted
enhancer (and without the promoter duplication) (Hack-proximately equal number of genes, 3 transgene copies
versus 3±4 endogenous genes, transgene transcription ett et al., 1990; O'Brien et al., 1987; Rogerson et al.,
1991). Second, the region upstream of the second pro-appears to be considerably lower than transcription of
the endogenous genes. However, since the transgene moter was not mutated, indicating the upstream muta-
tion tract had ended and, thus, the mutations seenhas a translational stop codon in each of the two leader
sequences, which may decrease the stability of the tran- downstream must have been newly initiated (Figure 4,
bottom). Furthermore, l genes have no enhancer in thescripts (Sachs, 1993), the real difference between en-
dogenous and transgenic transcription levels may be JC intron (the enhancers are located 16 kb and 35 kb
39 of C4 and C1, respectively), but are highly mutableless than 10-fold.
All six possible transcripts (upstream and downstream with a single distribution of mutations that peak over
the VJ region (a few mutations spill into the Cl region,promoter initiated transcripts from copies [a], [b], and
[c]) were found when RNAs of the hybridomas 3F2.2 presumably because of the short JC intron) (Motoyama
et al., 1991). Furthermore, a l transgene in which the lwere sequenced (data not shown). No transcripts
spliced from the leader to the C region were detected enhancer was placed at the same position 39 of the C
region as the k enhancer in P59C (Doglio et al., 1994) iseither in endogenous kmRNA or kmRNA of the control
transgenic mouse using RT±PCR (data not shown). mutated in the VJ region (E. Klotz and U. S., unpublished
data). It is possible, however, that the 39 position of theThus, the transgenic LC transcripts are most likely origi-
nating from the C promoter, and are not splice products k intron enhancer aided the expression from the second
promoter. Since at this position the enhancer is muchof pre-mRNAs originating at the V promoter. This is to
be expected, since short introns (V-leader to V, or closer to the C region promoter than to the V promoter
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(in the same transgene copy or in an adjacent one), the
enhancer has a greater likelihood of interacting with the
second promoter in analogy to the promoter/enhancer
competition model (Kim et al., 1992). Therefore, the in-
tron enhancer does not appear to have any local tar-
geting function in somatic hypermutation; its function
in mutation is position independent, just as in trans-
cription.
Since the region upstream of the k gene has the tar-
geting effect it appears likely that a process initiated
upstream carries a mutator factor into the gene. The
known cellular processes with such directionality are
DNA replication and transcription. DNA replication from
a fixed origin combined with a process that targets either
the leading or the lagging strand has been proposed as
a mechanism of somatic hypermutation (Rogerson et
al., 1991). In this model, a mutator factor would load
onto the leading strand of replication initiated at a bidi-
rectional origin located upstream of the V gene. A de-
fined mutation initiation region 59 of the transcription
start site would be the mutator loading site. However,
there is no evidence for specificity of the upstream re-
gion. When the V promoter is replaced by a b-globin
promoter, the quality of the mutations is the same and
the frequency is almost as high as with the V promoter
(Betz et al., 1994). Also, in search of a mutation initiation
Figure 5. Model of Somatic Mutation of Immunoglobulin Genes via
region we sequenced 1 kb upstream of Vk, Vl, and TCR
VH genes, but, besides known promoter elements, we
found no common motif (A. P. and U. S., unpublished
molecule, but they would then have to be converted intodata). Thus, there is no evidence for an upstream spe-
DNA by a reverse transcriptase and the altered DNAcific mutation initiation region as postulated by the repli-
would have to replace the chromosomal gene segment.cation model (Rogerson et al., 1991). Furthermore, the
A model of somatic mutation of immunoglobulin genesfact that the mutation rate of endogenous k genes is
based on reverse transcription has been proposedabout ten times higher than that of most k transgenes
(Steele and Pollard, 1987). However, reverse transcrip-(O'Brien et al., 1987) in parallel with the much greater
tion does not appear very likely, since a DNA primertranscriptional activity of endogenous genes favors a
would be required and, given that any sequence cantranscriptional model. Finally, the removal of transcrip-
apparently be hypermutated (Azuma et al., 1993; Ye-tional enhancers curtails somatic hypermutation (Betz
lamos et al., 1995; Klotz et al., submitted), it is difficultet al., 1994), whereas replication of the transgenes must,
to imagine how the varied primers would be created.of course, continue. For these reasons, we favor a tran-
Second, the factor could act after induction of tran-scription initiation-linked model.
scription-coupled repair (TCR) by increasing the error
rate of the DNA polymerase involved in TCR. In this
case, the factor would behave differently from the pro-Model of Somatic Mutation of Immunoglobulin
Genes through Transcription-Coupled Repair teins known to be involved in TCR (Friedberg, 1996).
Factors, such as components of TFIIH, are present inWhat may be the molecular mechanism linking somatic
mutation to the initiation of transcription? It is clear that the transcription initiating complex, but dissociate when
the RNA polymerase has begun to transcribe. Thus,the mutations in immunoglobulin genes only extend for
about 1.5 kb downstream of the transcription promoter factors such as TFIIH are not present in the elongating
transcription complex, but are recruited to the TCR after(Rogerson, 1994; Weber et al., 1991a, 1991b). Thus, they
cannot be due to a factor that indiscriminately targets stalling has occurred (Zawel et al., 1995; Svejstrup et
al., 1995; Friedberg, 1996). Because of the restriction ofthe whole immunoglobulin gene. Rather, it appears that
some error factor is loaded at transcription initiation, somatic mutation, but not TCR, to the first 1.5 kb of the
gene, it appears less likely that the mutator factor isbrought into the gene by the elongating transcription
complex, and released before about 1.5 kb of DNA have recruited only after stalling.
Finally, the factor could cause pausing of the tran-been transcribed.
There are several possible modes of action for a tran- scription complex and thus induce TCR (Mellon et al.,
1987; Selby and Sancar, 1993, 1994; Friedberg, 1996;scription initiation-linked mutator factor. First, its pres-
ence in the transcription complex could cause lesions Siede et al., 1995). A model is presented in Figure 5 in
which a mutator factor that is present only in mutatingin the transcribed DNA strand, but there is no precedent
for the induction of point mutations directly into DNA B cells loads on to the transcription initiation complex
assembled at the promoter and remains associated withsimply by transcription. Point mutations could, of
course, be introduced into the newly synthesized RNA the elongating complex. Immunoglobulin gene-specific
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loading may be regulated by the enhancers (see below). for introducing a point mutation is at best 1/25 elonga-
tion events (assuming ten cell generations and 100 tran-The mutator factor increases the inherent tendency of
scripts per generation), because, while pausing andthe RNA polymerase topause and aids in the recruitment
TCR-based excision of DNA may be frequent, filling inof transcription-coupled repair factors to the transcribed
of the excised patch, even by the low fidelity polymeraseDNA strand. ªGratuitousº TCR would occasionally cause
b (Kornberg and Baker, 1992), would rarely result in athe generation of point mutations, simply as a conse-
mutation.quence of replication errors (Hanawalt, 1994, 1995). The
An important open question in somatic hypermutationmutations would be permanently established in one of
is the specificity of the process. Since it has been shownthe daughter cells after the next round of the cell cycle.
that the V promoter can be replaced by a b-globin pro-This model is compatible with the observations made
moter (Betz et al., 1994) and the V region by a varietywith somatic mutation of immunoglobulin genes. Strand
of sequences (Azuma et al., 1993; Yelamos et al., 1995;bias would be explained, because only the transcribed
Klotzet al., submitted), what makes themutations immu-DNA strand is targeted. Hotspots would exist, because
noglobulin gene specific? The only sequence that hasthe rate of pausing and the rate of error introduction
so far been retained in all transgenic substrates thatduring gratuitous TCR depend on the primary DNA se-
were shown to be hypermutable is an immunoglobulinquence. Several transgenes were highly mutated that
enhancer (reviewed by Storb, 1996). In the k locus, thehad only 600 bp upstream of the transcriptional start
intron enhancer (ki), but not the 39 enhancer (k39), ap-
site (Betz et al., 1994; Yelamos et al., 1995), and the
pears to be indispensable (Yelamos et al., 1995). In the
b-globin promoter can replace the immunoglobulin pro-
l locus, the l enhancer suffices for somatic mutation
moter, suggesting that the only required upstream re-
(E. Klotz and U. S., unpublished data). Curiously, this
gion may be the transcriptional promoter. The mutations
enhancer has little homology with the ki enhancer, ex-
start downstream of the transcription start site (Rada et cept for certain E boxes, and more resembles the k39
al., 1994; Rogerson, 1994). Very rarely have mutations enhancer (Rudin and Storb, 1992; Eisenbeis et al., 1993).
been found within 400±600 nt upstream of the promoter Finally, heavy chain transgenes with only the heavy
(Both et al., 1990; Lebecque and Gearhart, 1990; Rog- chain intron enhancer (Sohn et al., 1993), or with both
erson, 1994). These could be explained by occasional heavy chain gene enhancers (Taylor et al., 1994; Giusti
transcriptional initiation from a cryptic promoter. The and Manser, 1993) and a l transgene with the heavy
mutations are limited to about the first 1.5 kb of the chain intron enhancer (E. Klotz and U. S., unpublished
immunoglobulin genes without a defined 39 end of the data) have beenfound to be mutated. Thus, if only immu-
mutation track (see Figure 4, top). Since TCR is not noglobulin genes are somatically mutated, the various
limited to the 59 region of a gene, the mutator factor must immunoglobulin enhancers would be responsible for the
not gain access to the rest of the gene. We postulate immunoglobulin gene specificity of the mutation pro-
that after recruitment of the TCR, the mutator factor cess. It is not clear how sequences as diverse as the k
dissociates from the transcriptional complex and must intron enhancer and the l enhancers, which bind a vari-
return to an initiating complex at the promoter or be ety of proteins involved in the regulation of other genes,
can determine immunoglobulin gene specificity in thedegraded. In this way, the proximity of the mutations to
absence of the V promoter. Somehow, interaction ofthe promoter would be explained by a high probability
an immunoglobulin enhancer with the promoter wouldof pausing early in elongation and no farther than 1.5
allow the loading of the mutator factor specifically onkb from the promoter. Furthermore, the absence of a
to an immunoglobulin gene transcription complex. Nodefined 39 end of the mutations would be due to the
direct evidence exists for theenhancer-dependent load-stochastic distribution of pausing sites. It appears that
ing of a specific factor. However, it has been found thatin mammalian cells during pausing the polymerase, to-
enhancer binding transactivator proteins determine thegether with the nascent transcript, backs up and re-
competence of the RNA polymerase to elongate (Yanku-mains tightly bound to the DNA upstream of a track of
lov et al., 1994). It was postulated that the transactivatorDNA that is being excised and resumes elongation after
proteins recruit elongating proteins to the initiation com-completion of the TCR (Hanawalt, 1994). As postulated,
plex (Yankulov et al., 1994). In keeping with this hypothe-the mutator factor would be absent from the reeÈ longat-
sis, the immunoglobulin enhancer-binding proteins
ing complex, thus avoiding further pausing.
would recruit the postulated mutator factor to the initia-
Most somatic mutations are pointmutations, compati-
tion complex. Alternatively, all RNA polymerase II genes
ble with occasional errors introduced during gratuitous that are highly expressed in the mutating B cells may
DNA repair. While the DNA polymerase involved in exci- be targets for theB cell±specific mutator. This possibility
sion repair is polymerase d or e, the one involved in TCR is under investigation.
is not yet known (Hanawalt, 1995). The patch size for While this model is speculative, it is compatible with
nucleotide excision repair is approximately 30 nt (Ede- the known features of somatic hypermutation, and its
nberg and Hanawalt, 1972; Huang et al., 1992; Hanawalt, overall validity can be experimentally tested.
1995) and is probably also short for TCR. Presumably,
an immunoglobulin gene undergoes hundreds of rounds Experimental Procedures
of transcription during the 5±10 cell generations while
Materialsthe mutation process is active (McKean et al., 1984;
The following materials were used: restriction endonucleases (New
Gearhart and Levy, 1991; Jacob et al., 1991). The highest England Biolabs, Boehringer Mannheim), T4 DNA ligase (New En-
mutation frequency ever observed in a mammalian V gland Biolabs), Klenow fragment (Boehringer Mannheim), Pfu ther-
mostable polymerase (Stratagene), Taq thermostable polymeraseregion is only z4 3 1022 mutations/nt. Thus, the chance
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(Perkin Elmer), AMV reverse transcriptase (Boehringer Mannheim), and ligated into BamHI cut pUC18. The ligation mixture was trans-
formed into DH5a. Cloned DNA was prepared using Wizard Mini-and cloning vector pKS(1) (Stratagene).
preps (Promega). Double-stranded sequencing was performed us-
ing the DNA sequencing kit with Sequenase Version 2.0 (United
Transgene Construction
States Biochemical). The primers used to sequence the variable
Plasmid P59C was created from the plasmid pVC167, which contains
region were Vk3t and Vk7 (59-GAGTGAAGGCTG AGGATGTG-39).
the rearranged Vk167 k light chain gene whose origin has been
The primers used to sequence the constant region were APC1 (59-
previously described (Selsing and Storb, 1981; Storb et al., 1986).
GCT GATGCTGCACCAACTG-39) and APC6 (59-CAGGACAGCAAAG
The intronic enhancer and matrix attachment region was deleted
ACAGC-39). The intervening sequence was amplified with Pfu poly-
from the J±C intron by deleting the HindIII±HincII region. The en-
merase and the primers KD-2 (CTGTTCCAACTTCCTACC) and ahancer and matrix attachment region in a HindIII±XmnI fragment
constant region specificprimer Ck3 (59-ACAGAGATCTCAAGTGCAAwas reinserted downstream of the constant region into a SacI site.
AGACTC-39). The products were cloned directly into EcoRV cutA stop codon was introduced into the leader exon by site-directed
pKS(1) vector. The insert was sequenced with the primers KD-2PCR mutagenesis as described (Kwok et al., 1994). The mutant
and KD-4 (59-AGGAGACAAGGTTTAGAGG-39). Additional sequenceprimers used were Vmu11 (59-CCTGGGGTGCTTATGTTCTAGATCT
on the mutant constant region clones was obtained using theCTGG-39) and Vmu21 (59-AACCAGAGATCTAGAACATAAGCACCC
constant region primer JRH1 (59-GATGTAGATTCAGGTGC-39),CCAGG-39). The mutation creates a BglII site that can be easily
and vector primers 1233 (59-AGCGGATAACAATTTC ACACAGGA-39)verified by digestion. The upstream four kilobase region contained
and 1224 (59-CGCCAGGGTTTTCCCAGTCACGA-39) (New Englandin a KpnI±SpeI fragment from pVC167 was inserted upstream of the
Biolabs).constant region by blunting the overhangs with Klenow and ligating
the fragment into an XmnI site 234 bp 59 of the constant region.
RNA Analysis
Whole cell and poly(A)1 RNAs were prepared from selected hybrido-
Transgenic Mice mas as described (Ausubel et al., 1995). RT±PCR was performed
P59C DNA was prepared for microinjection by digesting CsCl puri- as described (Hackett et al., 1992) with the following changes. The
fied plasmid (Maniatis et al., 1984) with EcoRI. The mixture was primers Ck3 and Vmu11 were used on 5 mg of total hybridoma RNA.
extractedwith phenol chloroform several timesand electrophoresed The products were blunt-end ligated into an EcoRV site in pKS(1).
on a 0.8% SeaKem low melt agarose (FMC) gel. The desired band Ribonuclease protection analysis was performed with the RPA II kit
was cut out of the gel, completely melted, and diluted 10-fold with (Ambion). The hybridization probe was a RT±PCR clone generated
Elutip Low Salt Buffer. The sample was isolated with an Elutip ac- from the hybridoma 3F2.2, consisting of the leader spliced to the
cording to the directions (Elutip-d Starter Kit, Schleicher and constant region. The transgene and, hence, the probe contain a 10
Schuell). The clean DNA was sent to the National Transgenic Devel- bp insertion at the HpaI site in the k constant region. Upon digestion
opment Facility (DNX, Princeton, New Jersey), where it was microin- with ribonuclease, the endogenous band is 60 bp shorter than the
jected into fertilized B6/SJL oocytes. Tail samples from the resultant transgenic band. Quantitation of the RPA blot was performed on
offspring were analyzed by Southern blot hybridization (Maniatis et the Phosphorimager 425E (Molecular Dynamics).
al., 1984) for the presence of the transgene. Two lines of mice were
created: line 333, with approximately 40 copies of the transgene, Acknowledgments
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